ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
Pavmed (MM)

Pavmed (MM) (PAVMU)

14.53
0.00
(0.00%)
終了 12月12日 6:00AM
14.53
0.00
( 0.00% )
プレマーケット: 9:00AM

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

主要統計と詳細

通貨
14.53
買値
10.44
売値
30.00
出来高
-
0.00 日の範囲 0.00
0.00 52 週間の範囲 0.00
前日終値
14.53
始値
-
時刻
最終取引時間
-
平均取引量 (3 か月)
-
財務取引量
-
VWAP
-

PAVMU 最新ニュース

PAVmed to Present at the Ladenburg Thalmann 2016 Healthcare Conference

PAVmed Inc. (Nasdaq:PAVM), a highly differentiated, multi-product medical device company, today announced that Lishan Aklog, M.D., PAVmed’s Chairman and Chief Executive Officer, will present...

PAVmed to Present at the Rodman & Renshaw 18th Annual Global Investment Conference

PAVmed Inc. (Nasdaq: PAVM), a highly differentiated, multi-product medical device company, today announced that Lishan Aklog, M.D., PAVmed’s Chairman and Chief Executive Officer, will...

PAVmed Inc. Announces Second Quarter 2016 Financial Results and Provides Business Update

- Conference Call to be Held August 17th- PAVmed Inc. (Nasdaq:PAVM) (“PAVmed” or the “Company”), a highly-differentiated multi-product medical device company, today announced financial...

PAVmed Announces Quarterly Conference Call and Webcast to Be Held on August 17, 2016

PAVmed Inc. (Nasdaq:PAVM), a highly differentiated, multi-product medical device company, today announced that the Company will host a conference call on August 17, 2016 at 4:30 p.m. Eastern...

PAVmed Announces Initiation of Research Coverage by The Benchmark Company

PAVmed Inc. (Nasdaq:PAVMU), a highly differentiated, multi-product medical device company, announced today that Jan David Wald, Ph.D., Senior Research Analyst at The Benchmark Company, has...

PAVmed Units to Separate into Common Stock and Warrants on July 27

-Common Stock (Nasdaq:PAVM) and Warrants (Nasdaq:PAVMW) will trade separately- -Units (Nasdaq:PAVMU) will cease trading upon separation- PAVmed Inc. (Nasdaq:PAVMU), a highly...

PAVmed Sets Q4 2016 Timeline for FDA Submission of Its First Product

-Commercialization of PortIO™ implantable vascular access device anticipated in 2017- PAVmed Inc. (Nasdaq:PAVMU), a highly differentiated, multi-product medical device company, announced...

ADDING MULTIMEDIA PAVmed Successfully Completes CarpX™ Pre-Clinical Study

- Device designed to revolutionize treatment of Carpal Tunnel Syndrome - - Completely percutaneous procedure would replace invasive surgery - PAVmed Inc. (Nasdaq:PAVMU), an...

PAVmed Successfully Completes CarpX™ Pre-Clinical Study

- Device designed to revolutionize treatment of Carpal Tunnel Syndrome - - Completely percutaneous procedure would replace invasive surgery - PAVmed Inc. (Nasdaq:PAVMU), an...

PAVmed CEO to Present at 2016 Marcum MicroCap Conference on June 2, 2016

PAVmed Inc. (Nasdaq:PAVMU), an innovative, multi-product medical device company developing and commercializing a diversified pipeline of innovative products utilizing a groundbreaking...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
PALIPalisade Bio Inc
US$ 3.20
(128.57%)
20.1M
SYTASiyata Mobile Inc
US$ 1.05
(40.37%)
12.24M
TRVITrevi Therapeutics Inc
US$ 3.40
(36.55%)
2.47M
ZENAZenaTech Inc
US$ 7.46
(31.11%)
3.6M
ATLNAtlantic International Corporation
US$ 7.00
(22.74%)
1
KROSKeros Therapeutics Inc
US$ 18.78
(-72.64%)
609.66k
SPGCSacks Parente Golf Inc
US$ 0.50
(-64.29%)
163.73k
PNBKPatriot National Bancorp Inc
US$ 1.08
(-58.78%)
16
AVGRAvinger Inc
US$ 0.441
(-46.22%)
87.3k
HEPAHepion Pharmaceuticals Inc
US$ 0.36
(-38.46%)
1
PALIPalisade Bio Inc
US$ 3.20
(128.57%)
20.1M
CDTConduit Pharmaceuticals Inc
US$ 0.1012
(14.61%)
14.2M
AMPGAmplitech Group Inc
US$ 2.20
(13.99%)
13.48M
SYTASiyata Mobile Inc
US$ 1.05
(40.37%)
12.24M
LAESSEALSQ Corporation
US$ 1.245
(8.26%)
8.74M